Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 ...

Italian hybrid innovation clashes with American muscle as the Ferrari 296 GTB faces the Chevrolet Corvette Stingray C7 in a ...

Stocks have been hitting records in large part because Wall Street is expecting the economy to pull off a delicate balancing ...

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

The explosive rise of GLP-1 medications—such as Mounjaro, Ozempic, and Wegovy—has ignited more than just headlines. It has fundamentally shifted how Americans access and pay for medications, driving ...

Oracle co-founder Larry Ellison wrested the title of the world’s richest man from longtime holder Elon Musk early Wednesday, ...

The Danish pharmaceutical company Novo Nordisk is cutting 9,000 jobs, 4,000 of which will be outside Denmark. The company, ...

Novo Nordisk will lay off 9,000 employees worldwide as part of a restructuring plan, redirecting savings to diabetes and obesity drug growth.

The draft assessment finds that the popular weight loss drugs are costly but worth the price tag, while also urging for ...

Wall Street closed mostly higher to notch more records. The S&P 500 added 0.3% Wednesday and set an all-time high for a ...

The maker of the popular weight-loss drug Wegovy announced on Wednesday that it will be cutting 9,000 jobs in the company.